| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |